Notably, the refractory hyponatremia is a characteristic feature of anti-LGI1 AE, and 60%~ 88% of the patients with anti-LGI1 antibodies may develop hyponatremia during the course of the disease [41, 42]. This evidence concerns the gene LGI1 and Hyponatremia.